Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2000, p. 4135-4148, Vol. 20, No. 11
Division of Biology, California Institute of
Technology, Pasadena, California 91125,1 and
Biobehavioral Sciences Graduate Program2
and Department of Psychology,3
University of Connecticut, Storrs, Connecticut 06269-4154
Received 30 December 1999/Returned for modification 28 February
2000/Accepted 8 March 2000
The N-end rule relates the in vivo half-life of a protein to the
identity of its N-terminal residue. N-terminal asparagine and glutamine
are tertiary destabilizing residues, in that they are enzymatically
deamidated to yield secondary destabilizing residues aspartate and
glutamate, which are conjugated to arginine, a primary destabilizing
residue. N-terminal arginine of a substrate protein is bound by the
Ubr1-encoded E3 A multitude of regulatory circuits
involve conditionally or constitutively short-lived proteins (26,
27, 44, 48, 49, 64). Features of proteins that confer metabolic
instability are called degradation signals, or degrons (37,
63). The essential component of one degradation signal, termed
the N-degron, is a destabilizing N-terminal residue of a protein
(3). A set of N-degrons containing different N-terminal
residues which are destabilizing in a given cell yields a rule, termed
the N-end rule, which relates the in vivo half-life of a protein to the
identity of its N-terminal residue. An N-end rule pathway is present in
all organisms examined, from mammals and plants to fungi and
prokaryotes (63).
In eukaryotes, an N-degron comprises two determinants: a destabilizing
N-terminal residue and an internal lysine of a substrate protein
(4, 32, 60). The Lys residue is the site of formation of a
substrate-linked multiubiquitin chain (15, 49). The N-end rule pathway is thus one pathway of the ubiquitin (Ub) system (25-27). Ub is a 76-residue eukaryotic protein that exists
in cells either free or covalently conjugated to many other proteins.
The Ub system plays a role in a vast range of processes, including cell
growth, division, differentiation, and responses to stress. In most of
these processes, Ub acts through routes that involve the degradation of
Ub-protein conjugates by the 26S proteasome, an ATP-dependent
multisubunit protease (10, 17, 20, 51).
(Throughout the text, the names of mouse genes are in italics, with the
first letter uppercase. The names of human and Saccharomyces cerevisiae genes are also in italics, all uppercase. If human and
mouse genes are named in the same sentence, the mouse gene notation is
used. The names of S. cerevisiae proteins are roman, with
the first letter uppercase and an extra lowercase "p" at the end.
The names of mouse and human proteins are the same, except that all
letters but the last "p" are uppercase. The latter usage is a
modification of the existing convention [58], to
facilitate simultaneous discussions of yeast, mouse, and human
proteins. In some citations, the abbreviated name of a species precedes the gene's name.)
The N-end rule has a hierarchic structure. In the yeast S. cerevisiae, Asn and Gln are tertiary destabilizing N-terminal
residues in that they function through their conversion, by the
NTA1-encoded N-terminal amidohydrolase (Nt-amidase), into
the secondary destabilizing N-terminal residues Asp and Glu
(6). Destabilizing activity of N-terminal Asp and Glu
requires their conjugation, by the S. cerevisiae
ATE1-encoded Arg-tRNA protein transferase (R-transferase) (8,
41), to Arg, one of the primary destabilizing residues (Fig.
1A). In mammals, the deamidation step is
mediated by two Nt-amidases, NtN-amidase and
NtQ-amidase, which are specific, respectively, for
N-terminal Asn and Gln (Fig. 1A) (24, 59). The mammalian
counterpart of the yeast R-transferase Ate1p exists as two distinct
species, ATE1-1p and ATE1p-2, which are produced through alternative
splicing of Ate1 pre-mRNA (34). In vertebrates,
the set of secondary destabilizing residues contains not only Asp and
Glu but also Cys, which is a stabilizing residue in yeast (Fig. 1A)
(18, 23). The primary destabilizing N-terminal residues are
bound directly by the UBR1-encoded N-recognin, the targeting
(E3) component of the N-end rule pathway. In S. cerevisiae,
Ubr1p is a 225-kDa protein which recognizes potential N-end rule
substrates through its type 1 and type 2 substrate-binding sites. The
type 1 site binds the basic N-terminal residues Arg, Lys, and His. The
type 2 site binds the bulky hydrophobic N-terminal terminal residues
Phe, Leu, Trp, Tyr, and Ile (35, 63). Ubr1p contains yet
another substrate-binding site that targets proteins such as Cup9p and
Gpa1p, which bear internal (non-N-terminal) degrons (12,
54). The Ubr1 genes encoding mouse and human
N-recognins, also called E3
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Altered Activity, Social Behavior, and Spatial
Memory in Mice Lacking the NTAN1p Amidase and the Asparagine Branch of
the N-End Rule Pathway


![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, the E3 component of the
ubiquitin-proteasome-dependent N-end rule pathway. We describe the
construction and analysis of mouse strains lacking the
asparagine-specific N-terminal amidase (NtN-amidase),
encoded by the Ntan1 gene. In wild-type embryos,
Ntan1 was strongly expressed in the branchial arches and in
the tail and limb buds. The Ntan1
/
mouse
strains lacked the NtN-amidase activity but retained
glutamine-specific NtQ-amidase, indicating that the two
enzymes are encoded by different genes. Among the normally short-lived
N-end rule substrates, only those bearing N-terminal asparagine became
long-lived in Ntan1
/
fibroblasts. The
Ntan1
/
mice were fertile and outwardly
normal but differed from their congenic wild-type counterparts in
spontaneous activity, spatial memory, and a socially conditioned
exploratory phenotype that has not been previously described with other
mouse strains.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, have been cloned (36), and
mouse strains lacking Ubr1 have recently been constructed (Y. T. Kwon and A. Varshavsky, unpublished data).

View larger version (40K):
[in a new window]
FIG. 1.
Deletion-disruption of the mouse Ntan1 gene.
(A) Comparison of enzymatic reactions that underlie the activity of
tertiary and secondary destabilizing residues in the yeast S. cerevisiae and the mouse. N-terminal residues are indicated by
single-letter abbreviations for amino acids. The ovals denote the rest
of a protein substrate. The Ntan1-encoded mammalian
NtN-amidase converts N-terminal Asn to Asp. N-terminal Gln
is deamidated by NtQ-amidase, which remains to be isolated
(see text). In contrast, the yeast Nt-amidase Nta1p can deamidate
either N-terminal Asn or Gln (6). The secondary
destabilizing residues Asp and Glu are arginylated by the mammalian
ATE1-1p or ATE1-2p R-transferase (34). A Cys-specific
mammalian R-transferase (23) remains to be identified.
N-terminal Arg, one of the primary destabilizing residues, is
recognized by N-recognin, the E3 component of the N-end rule pathway
(63). (B) Targeting strategy. Top, partial restriction map
of the mouse Ntan1 gene; middle, structure of the targeting
vector; bottom, structure of the deletion-disruption
Ntan1
allele. Exons are denoted by solid
vertical bars. The directions of transcription of the neo
and tk genes are indicated. Homologous recombination
resulted in the replacement of the Ntan1 exons 2 to 5 with
the neo cassette. Probes for Southern hybridization are
indicated by solid rectangles. Restriction sites: Xh, XhoI;
R, EcoRI; BI, BamHI; H, HindIII;
P, PstI. (C) Southern analysis of BamHI-digested
tail DNA from wild-type (+/+), heterozygous
(Ntan1+/
), and
Ntan1
/
mice. The 5' probe yielded the 12- and 1.7-kb Ntan1 fragments for the wild-type (wt) and mutant
(mut) Ntan1 alleles, respectively; the 3' probe detected 12- and 7-kb fragments. The organization of the deletion-disruption allele
was independently verified by Southern analysis of the
XhoI-HindIII-digested tail DNA (data not
shown). (D) PCR analysis of tail DNA. The primers were
5'-GCCACTTGTGTAGCGCCAAGTGCCAGC (for neo,
forward), 5'-CTTCCCACCAAGCCTGACTGTTGATC (for
Ntan1, forward) and 5'-CTTCAATTTCTGTGCTCAGCTAAGCTC
(for Ntan1, reverse). (E) RT-PCR analysis of the total
RNA isolated from +/+ and Ntan1
/
EF cells,
using primers P1 (for exon 1), P2 (exon 2), P3 (exon 6), P4 (exon 5),
and P5 (exon 10).
-Actin mRNA was used as a control, at the
20-fold-lower primer concentration in comparison to other lanes.
The known functions of the N-end rule pathway include the control of
peptide import in S. cerevisiae, through the degradation of
Cup9p, a transcriptional repressor of PTR2, which encodes
the peptide transporter (1, 12); a mechanistically undefined role in regulating the Sln1p-dependent phosphorylation cascade that
mediates osmoregulation in S. cerevisiae (47);
the degradation of alphaviral RNA polymerases and other viral proteins
in infected metazoan cells (19, 38); and the degradation of
Gpa1p, a G
protein of S. cerevisiae (43, 54).
Physiological N-end rule substrates were also identified among the
proteins secreted into the mammalian cell's cytosol by intracellular
parasites such as the bacterium Listeria monocytogenes.
Short half-lives of these bacterial proteins are required for the
efficient presentation of their peptides to the immune system
(56). Inhibition of the N-end rule pathway was reported to
interfere with mammalian cell differentiation (28) and to
delay limb regeneration in amphibians (61). Studies of the
Ub-dependent proteolysis of endogenous proteins in muscle extracts
suggested that the N-end rule pathway plays a role in catabolic states
that result in muscle atrophy (39, 57). A crush injury to
the rat sciatic nerve was reported to result in a ~10-fold increase
in the rate of arginine conjugation to the N termini of proteins in the
nerve's region upstream of the crush site, suggesting an
injury-induced increase in the concentration of R-transferase
substrates and/or an enhanced activity of the N-end rule pathway
(65).
Physiological substrates of either yeast or metazoan Nt-amidases and R-transferases are unknown. Engineered N-end rule substrates, including substrates of Nt-amidases and R-transferases, can be produced in vivo through the Ub fusion technique, in which a Ub-X reporter fusion is cleaved by deubiquitylating enzymes (DUBs) (66) after the last residue of Ub, yielding a reporter bearing the desired N-terminal residue X (3, 63).
The mouse Asn-specific NtN-amidase is encoded by the 17-kb
Ntan1 gene. The 1.6-kb Ntan1 mRNA specifies the
310-residue NtN-amidase (24). In the present
work, we characterized the expression and intracellular localization of
NtN-amidase. We also constructed mouse strains bearing a
homozygous deletion-disruption of Ntan1 and showed that
these mice lacked both NtN-amidase and the Asn-specific
branch of the N-end rule pathway. The Ntan1
/
mice were fertile and outwardly normal but were found to differ from
their congenic wild-type counterparts in spontaneous activity and
spatial memory. Among these differences was a socially conditioned exploratory phenotype of Ntan1
/
mice that
has not been previously described, to our knowledge, with other mouse strains.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Construction of mouse strains lacking
NtN-amidase.
Genomic Ntan1 DNA fragments
were subcloned from the P1 phage DNA containing the strain C129-derived
mouse Ntan1 gene (24). The 1,462-bp
HindIII-PstI fragment containing exon 6 and
its flanking introns was used as the vector's short homology arm. The
7.2-kb XhoI-NotI fragment containing exon 1 and
its flanking intron was used as the long homology arm. To construct the
targeting vector, a 1,462-bp HindIII-PstI
fragment containing exon 6 and its flanking introns (the vector's
short arm) and the phosphoglycerate kinase gene
(PGK)-thymidine kinase (tk) cassette of pPNT (a
gift from R. C. Mulligan, Harvard Medical School, Boston, Mass.)
were inserted into pPGKRN containing the wild-type PGK-neo
(neomycin resistance gene) cassette (a gift from R. Jaenisch, Whitehead
Institute, Cambridge, Mass.), yielding pPGK-SA. The vector's 7.2-kb
long arm was produced by joining, within pPGK-SA, a 4.8-kb
XhoI-EcoRI fragment to its flanking 2.6-kb
EcoRI-EcoRI fragment containing exon 1 and
flanking intron pPGK-SA, yielding the Ntan1 targeting vector
pNTAN1-KO (Fig. 1B). The XhoI-linearized targeting vector (Fig. 1B) was electroporated into CJ7 embryonic stem (ES) cells. Selection with G418 (at 0.4 mg/ml) and 1-(2'-deoxy, 2'
fluoro-
-D-arabinofuranosyl)-5-iodouracil (FIAU; at 0.4 µM) was started 24 h after electroporation. Correctly targeted
ES cells were identified by PCR and Southern hybridization with the 5'
and 3' probes (Fig. 1C and D). Cells of the 12 independent ES cell
clones were injected into 3.5-days-postcoitum C57BL/6J blastocysts. The
resulting male chimeras were bred with C57BL/6J females to test for
germ line transmission of the mutated Ntan1 gene. The
Ntan1+/
mice resulting from this cross (6 out
of 12 independent ES clones were found to populate germ line in these
tests) were intercrossed to produce Ntan1
/
mice. Alternatively, the initial male chimeras were mated with 129/SvEv
females, yielding, through the analogous series of steps, Ntan1
/
mice in the strain 129 background.
All of the behavioral tests were carried out with
Ntan1
/
mice in the strain 129 background.
For genotyping, the tail-derived DNA was analyzed by PCR, or digested
with either BamHI or HindIII/XhoI, and analyzed by Southern hybridization. A 0.75-kb PstI
fragment and a 0.9-kb PstI fragment (indicated in Fig. 1B)
were used as the 5' and 3' hybridization probes, respectively.
Northern and RT-PCR analyses of RNA.
Total RNA was isolated
from brain, testis, and embryonic fibroblasts (EF cells) of wild-type
and Ntan1
/
mice as described elsewhere
(34). RNA was fractionated by electrophoresis in 1%
formaldehyde-agarose gels, blotted onto Hybond N+
(Amersham), and hybridized with 32P-labeled probes specific
for different regions of the Ntan1 cDNA (GenBank accession
no. U57692): probe a, nucleotide (nt) 34 to 900; probe b, nt 118 to
450; probe c, nt 118 to 900; probe d, nt 34 to 450; probe e, nt 470 to
670; and probe f, nt 680 to 900. Alternatively, reverse
transcription-PCR (RT-PCR) was carried out (2), with
first-strand cDNA synthesized using Superscript II polymerase (GIBCO,
Frederick, Md.). PCR was done using primers specific for different
regions of the Ntan1 cDNA: primer P1,
5'-ATGCCACTGCTGGTGGATGG-GCAG (forward); P2,
5'-GAGCCAGACTTCTCAGAGGTCAG (forward); P3,
5'-GACA-TTCACTTAGTGACATTATG (forward); P4,
5'-TTCTGTGACAGCTGCCTGTCATC (reverse); and P5,
5'-CATCAAGGTAGATCTAATATGTTC (reverse). The ratio of mouse
Ate1-1 and Ate1-2 mRNAs was determined as
described elsewhere (34).
Whole-mount in situ hybridization.
Wild-type and
Ntan1
/
embryos were staged, fixed, and
processed for in situ hybridization as described elsewhere
(16). A 0.3-kb fragment of the Ntan1 cDNA (nt 108 to 448) that was encompassed by the deleted region in the
Ntan1
/
allele was subcloned into
XbaI-XhoI sites of pBluescript II SK+
(Stratagene), and the resulting plasmid, pMR27, was used as a template
for synthesizing antisense RNA probe labeled with digoxigenin (Roche
Molecular Biochemicals, Indianapolis, Ind.).
Localization of NTAN1p-GFP. The mouse Ntan1 open reading frame (ORF) was subcloned into the XhoI and AgeI sites of pEGFP-N1 (Clontech), yielding pNTAN1-GFP, which expressed the NTAN1p green fluorescent protein (GFP) fusion from the cytomegalovirus promoter. NIH 3T3 cells (ATCC 1658-CRL) were grown as monolayers in Dulbecco's modified Eagle medium (DMEM; Gibco-BRL) supplemented with 10% fetal bovine serum. Cells were grown to ~15% confluence on glass coverslips for 24 h prior to transfection with either the GFP-expressing control vector pEGFP-N1 or pNTAN1-GFP, using Lipofectamine (GIBCO) and the manufacturer-supplied protocol. Cells were incubated for 5 h at 37°C in serum-free DMEM containing DNA and Lipofectamine. An equal volume of medium containing 20% serum was then added, and the cells were grown for another 12 to 20 h at 37°C. Cells were fixed with 2% formaldehyde in phosphate-buffered saline, and GFP fluorescence was examined in a Zeiss Axiophot microscope.
Immortalization of EF cells, transfection, and pulse-chase
analysis.
EF cells were isolated from either
Ntan1
/
or +/+ 13.5-day-old (e13.5) embryos
as described elsewhere (52) and grown in DMEM-F-12 (GIBCO)
supplemented with 15% fetal bovine serum, antibiotics, and 2 mM
L-glutamine. They were immortalized using simian virus 40 (14) and then transiently transfected, using Lipofectamine PLUS (GIBCO), with plasmid pRC/dhaUbXnsP4
gal, which expressed DHFR
(dihydrofolate reductase)-HA
(hemagglutinin)-UbR48-X-nsP4
gal test proteins (X = Met, Asn, Gln, or Arg) (40) (see Results). Cells were
labeled with Tran35S-label (New England Nuclear, Boston,
Mass.), followed by a chase for 0, 1, and 2 h in the presence of
cycloheximide, preparation of extracts, immunoprecipitation, sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
autoradiography, and quantitation with PhosphorImager, essentially as
described elsewhere (40).
X-DHFR test proteins.
35S-labeled X-DHFR
proteins (X = Asn, Gln, or Asp) were prepared as described
elsewhere (24). Briefly, plasmids pSG4, pSG41, and pSG44,
expressing, respectively, Ub-Asn-DHFR, Ub-Asp-DHFR, and Ub-Gln-DHFR
from the Ptrc promoter (24), were transformed into Escherichia coli JM101 carrying pJT184, which expressed
Ubp1p, a DUB of S. cerevisiae (62). Cells of a
50-ml culture grown at 37°C to an A600 of
~0.9 in Luria broth plus ampicillin (40 µg/ml) and chloramphenicol
(20 µg/ml) were pelleted and resuspended in 50 ml of M9 supplemented
with glucose (0.2%), thiamine (2 µg/ml), ampicillin (40 µg/ml), 1 mM isopropylthio-
-D-galactoside (IPTG), and methionine
assay medium (Difco). The suspension was shaken for 1 h at 37°C,
followed by the addition of 1 mCi of Tran35S-label (ICN)
and further incubation for 1 h at 37°C. Unlabeled L-methionine was then added to 1 mM, and shaking was
continued for another 10 min. The cells were harvested, and lysates
were prepared by the addition of lysozyme and Triton X-100, followed by
centrifugation (24). The supernatant, containing
[35S]X-DHFR (X = Asn, Asp, or Glu) was purified by
affinity chromatography on a methotrexate column (Pierce) (0.5-ml bed
volume). [35S]X-DHFRs were examined by SDS-PAGE and found
to be greater than 95% pure.
IEF assay for amidase activity.
Extracts from wild-type or
Ntan1
/
EF cells were prepared by
homogenization in a mixture containing 0.01% Triton X-100, 10% glycerol, 125 mM KCl, 7.5 mM MgCl2, 1 mM dithiothreitol,
0.25 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 130 mM Tris-HCl (pH
7.5), and the protease inhibitors antipain, chymostatin, leupeptin, pepstatin, and aprotinin (Sigma), each at 25 µg/ml. For the
deamidation assay, 5 µl of 35S-labeled X-DHFR (0.5 mg/ml
in storage buffer; X = Asn, Asp, or Glu) was mixed with 20 µl of
the extract, incubated for 2 h at 37°C, and placed on ice.
Samples (5 µl) were applied onto isoelectrofocusing (IEF)-PAGE plates
(pH 3.5 to 9.5; Pharmacia, Piscataway, N.J.) precooled to 10°C. IEF
was carried out for 80 min at 30 W in a cooled IEF apparatus (Hoefer,
San Francisco, Calif.). The plates were soaked in 100 ml of 10%
CCl3COOH-5% 5-sulfosalicylic acid, stained with Coomassie
blue to detect IEF markers (Pharmacia), and autoradiographed.
35S in the bands of more acidic (deamidated) and more basic
(initial) X-DHFR species was quantitated with a PhosphorImager
(Molecular Dynamics, Sunnyvale, Calif.).
Behavioral tests.
Mice were kept on a 0600- to 1800-h light
cycle and tested during the light period. For the rotarod, weight
retention, coat hanger, and platform-leaving tests, strain 129 Ntan1
/
mice and their congenic +/+
littermates (produced through matings of
Ntan1
/+ mice) were used. Nonlittermates were
also used for the platform-leaving test (see below). For the shuttlebox
and passive avoidance tests, the elevated plus-maze test, the
open-field test, the Morris maze, the radial arm maze, and the Lashley
maze, strain 129 +/+ and congenic Ntan1
/
mice (produced, respectively, through +/+ × +/+ and
Ntan1
/
× Ntan1
/
matings) were used. The same series
of tests were repeated 6 weeks or more after the initial experiment,
using both male and female mice. To determine whether the
Ntan1 genotype affected long-term memory, mice were retested
in the Morris maze, Lashley maze, and shuttlebox avoidance test at
least 7 weeks after their original learning. The data were evaluated by
analysis of variance. Significance was set at the 0.05 level; all
behavioral differences described in Results were at this or a higher
level of statistical significance.
(i) Rotarod test. The apparatus (UGO, Basile, Italy) consisted of a motor-driven rod 3 cm in diameter that carried five compartments, separated by walls 25 cm in height. One pair of littermates was placed on the rotating rod in each compartment. Mice were placed on the rod at either 10 or 20 rpm; the cutoff time was 2 min. Each mouse was tested on the rod six times, at 1-h intervals.
(ii) Weight retention. Mice were suspended by the tails and made to grab a wire loop (wire diameter, 2 mm; weight, 40 g) 70 cm above the floor. Time elapsed before the animal released the loop was measured. Each mouse was tested five times a day, at 1-h intervals, for a total of 3 days.
(iii) Coat hanger test. A wire coat hanger (wire diameter, 2 mm; length of side bars, 29 cm; length of the horizontal bar, 45 cm) suspended 75 cm above the table was used to examine motor coordination (11). A trial began by allowing the mouse to grab the middle of the horizontal bar with two front paws. The time elapsed before the animal grabbed the horizontal bar with all four paws and the time before the two front paws reached one of the side bars were determined. Each mouse in the trial was tested twice a day, at 6-h intervals, for 9 days.
(iv) Shuttlebox avoidance, passive avoidance, and elevated plus-maze tests. For the shuttlebox and passive avoidance tests, the Gemini avoidance system (San Diego Instruments, San Diego, Calif.) was used. The procedures are described in Results.
(v) Open-field test. For the open-field activity measurements, an Omnitech Digiscan animal activity monitor was used. Each mouse was placed into a square chamber (20 by 20 cm) for one 9-min session, and the movements were tabulated along the x and y axes, using infrared sensors.
(vi) Morris maze. A mouse was placed into a circular black water tub (diameter, 123 cm; temperature, 19 to 21°C) from one of the four quadrants and had to find a platform (diameter, 23 cm) submerged 1 cm below the surface of water and set 23 cm from the wall. There were no cues within the maze, and so the animal had to use extramaze spatial cues in guiding itself to the platform in repeated trials (46). An animal was given four trials per day (maximum of 45 s per trial), one from each of the four locations, their order determined quasi-randomly. Each mouse was tested for 5 days, with the platform in a fixed position. On day 6, the platform was moved to the quadrant diagonally opposite its previous location, and each mouse was given four trials, as before. This regimen is referred to as reversal learning. The mice were retested (with the platform in the original position) 7 or 8 weeks later. The animal's path was traced on an electronic digitizing tablet containing a template of the maze (22). The following parameters were recorded: total time, distance traveled, average speed, and percentage of time spent in each quadrant of the maze.
(vii) Spatial radial arm maze. The apparatus and testing procedure were described previously (30). Hidden escape platforms were placed at the ends of four of the eight identical arms which radiated from the central area. During training the animal was released from a start arm and had to find one of the escape platforms. Once a platform was found, the arm containing that platform was blocked. The training session consisted of four trials in which a mouse had to locate all four platforms. This was followed by 11 testing sessions which differed from the training session only by removing the platform while the mouse was in its home cage between trials. Thus, on successive trials, the animal had to remember which alleys it had previously entered and not enter those alleys again. The score was total errors obtained by summing together Working Memory Correct errors, Working Memory Incorrect errors, and Reference Memory errors (30).
(ix) Nonspatial radial arm maze learning. The nonspatial swimming radial arm maze apparatus and testing procedure were similar to the above spatial version, except for the following. Each of the arms was painted in a different black/white pattern: solid black, solid white, vertical stripes, horizontal stripes, black with white polka dots, white with black polka dots, zigzags, and the galvanized steel gray color (the start arm). The patterned arms which contained platforms were different for each mouse but remained constant throughout the testing of a given mouse. For the training session (session 1), the entrance to the arm with the just chosen platform was blocked; in addition, the maze was quasi-randomly rotated, so that each patterned arm now pointed toward a different place in space. As in the spatial version, the test sessions (sessions 2 to 12) were the same as the training session, except that while the mouse was in its home cage, each platform it found was removed from the maze, and the arm's entrance remained open for the remainder of the session. Over eight trials, or two sessions, each patterned arm pointed toward each of the eight spatial locations in the testing room. The errors were scored as above.
(x) Lashley maze learning. This maze contained cul-de-sacs that an animal had to learn to avoid, along with choices that required the animal to learn making correct left or right turns (T-choices). A water version of the maze was used, with the temperature at 19 to 20°C (21). All mice were given one trial per day for 5 days. An animal can learn this maze using two mutually nonexclusive strategies: by memorizing extramaze spatial cues, or by memorizing the sequence of correct left and right turns. The measures of learning included the learning index, defined as the number of correct entries divided by total number of entries, the number of cul entries (entries into dead ends) when swimming forward (i.e., toward the goal), number of forward T-choice errors, and the total number of backward errors. Retention testing was done 7 weeks later for experiment 1 and 8 weeks later for experiment 2.
(xi) Platform-leaving test.
To compare the exploratory
activities of two previously untested mice on the same platform, we
devised the platform-leaving test. One
Ntan1
/
mouse of strain 129 and one congenic
+/+ mouse of the same gender (either a littermate or a nonlittermate)
were placed, at the same time, on the platform (16 by 22 cm) 2.7 cm
above the surface of a laboratory bench. For each test, the platform
was covered with fresh white paper. Mice were allowed to either explore
or step down from the platform up until the cutoff time of 3 min.
(Step-down was recorded when all four paws of a mouse were no longer in
contact with platform.) The number and genotypes of mice leaving the
platform first, and the number of mice not leaving by 3 min, were
recorded. A total of three trials, at 1-h intervals, were carried out
for every pair of mice tested on a given day. Each set of tests
employed ~10 pairs of mice 2 to 4 months old. Four independent sets
of tests, with previously untested mice, were carried out over a period
of 6 months.
| |
RESULTS |
|---|
|
|
|---|
Construction of Ntan1
/
mice.
A
deletion-disruption allele of the ~17-kb mouse Ntan1 gene
was constructed by replacing Ntan1 exons 2 to 5 with a
neo cassette (Fig. 1B). Exons 2 to 5 encoded a 118-residue
region of the 310-residue NTAN1p (NtN-amidase) that was
significantly conserved among the NTAN1p proteins of different species,
including the plant Arabidopsis thaliana, the fly
Drosophila melanogaster, and mammals (data not shown). Of
the ~1,000 ES cell clones (strain 129/CJ7) resistant to both G418 and
FIAU, 33 clones contained the expected mutation, as verified by PCR and
Southern analyses (data not shown). Twelve of these correctly targeted
ES cell clones were used to generate male chimeras, and in six of them
the Ntan1
allele was transmitted through the
germ line. Male chimeras were mated with either 129/SvEv or C57BL/6
females, yielding Ntan1+/
heterozygotes.
Intercrosses of heterozygous mice produced
Ntan1
/
progeny at the expected frequency of
approximately one in four (Fig. 1C and D), indicating that the absence
of NTAN1p did not increase embryonic lethality. The behavioral tests
described below used exclusively Ntan1
/
mice
produced through matings in the strain 129 background.
Expression of Ntan1 and intracellular localization of
NTAN1p.
Several regions of Ntan1 transcripts were
analyzed using RT-PCR with RNA from wild-type and
Ntan1
/
EF cells. The level of
Ntan1-derived RNA in the Ntan1
/
EF cells was below the RT-PCR detection threshold (Fig. 1E and data not
shown). Northern hybridization analyses, using probes encompassing
either exons 2 to 5 (the deleted region) or exons 1 to 5 detected the
1.4- and 1.6-kb Ntan1 mRNAs, respectively, in the brains and
testes of +/+ mice; the +/+ testes also contained the
Ntan1-derived RNAs of 1.1 and 4 kb (Fig.
2A). No Ntan1 transcripts were
detected in the brains and testes of Ntan1
/
mice with these probes (Fig. 2Ab and d).
|
/
mice (Fig. 2Aa and c). However, in
the testes of Ntan1
/
mice, the same probes
detected 1.1- and 4-kb Ntan1-derived, testis-specific transcripts but not the 1.6-kb transcript (Fig. 2Aa and c). Further mapping, using the probes shown in Fig. 2C, indicated that the 1.1- and
4-kb transcripts hybridized to Ntan1 exons 6 to 10 and exons
9 and 10, respectively (Fig. 2Ae and f). These transcripts were
detected with antisense but not sense probes (data not shown), indicating a direction of transcription identical to that for the
full-length Ntan1 mRNA. Thus, the testes but not the brains of Ntan1
/
mice contained a set of
Ntan1-derived transcripts that lacked the 5' half of the
Ntan1 ORF (including the region deleted in Ntan1
/
mice) and encompassed its 3' half.
Apparently the same transcripts were present in the +/+ testes (Fig.
2Ae and f). Whether these testis-specific transcripts are
physiologically relevant remains to be determined.
We also examined by Northern analysis whether the expression of other
components of the N-end rule pathway was altered in the
Ntan1
/
mice. No changes in the expression of
either Ubr1 (encoding the E3 of the N-end rule pathway) or
Ate1 (encoding R-transferase [34]; see the
introduction) were detected in the brains and testes of
Ntan1
/
mice (Fig. 2B). The expression of
Ubr2 and Ubr3 (homologs of Ubr1; Kwon
and Varshavsky, unpublished data) and of mHR6B, encoding the
E214K Ub-conjugating (E2) enzyme, was also unchanged in the Ntan1
/
mice (data not shown). In addition,
no alterations in the ratio of Ate1-1 mRNA to
Ate1-2 mRNA, which encode two splicing-derived forms of the
mouse R-transferase (34), was detected in the brains, testes, and EF cells of Ntan1
/
mice (data
not shown).
Ntan1 was expressed in most if not all tissues of adult mice
(24). Whole-mount in situ hybridization was used to examine the expression of Ntan1 in +/+ mouse embryos. In e9.75
embryos, Ntan1 was most strongly expressed in the branchial
arches, the tail bud, and the forelimb buds; the same probe detected no
signal in the Ntan1
/
embryos (Fig.
3A). In e10.5 and e11.5 embryos, the
expression of Ntan1 became high in the hindlimb buds as
well; this expression pattern was indistinguishable from that of
Ubr1 (Fig. 3A), consistent with the assignment of NTAN1p and
UBR1p to the same pathway.
|
Ntan1
/
mice lack
NtN-amidase and the asparagine-specific branch of the N-end
rule pathway.
To determine whether
Ntan1
/
EF cells lacked
NtN-amidase activity, we used a previously described assay
(24). The 35S-labeled X-DHFR test proteins
(X = Asn, Gln, or Asp) were incubated with a whole-cell extract
and thereafter fractionated by IEF, which separated Asn-DHFR and
Gln-DHFR from Asp-DHFR and Glu-DHFR, respectively. Incubation of
Asn-DHFR with the extract from +/+ EF cells shifted the pI of this
protein to that of Asp-DHFR. In contrast, the pI of Asn-DHFR remained
unchanged after an otherwise identical incubation with the same amount
of extract from Ntan1
/
EF cells (Fig.
4A). The pI of Gln-DHFR shifted to that
of Glu-DHFR after incubations with either +/+ or
Ntan1
/
extracts (Fig. 4A). Thus,
Ntan1
/
EF cells lacked
NtN-amidase activity but contained wild-type amounts of the
Gln-specific NtQ-amidase. The latter result indicated that
the putative mammalian NtQ-amidase (which remains to be
isolated and cloned) is encoded by a gene distinct from
Ntan1.
|
/
EF cell lines were transiently
transfected with plasmids that expressed X-nsP4
gal test proteins
(X = Met, Asn, Gln, or Arg). An X-nsP4
gal was expressed as part
of a fusion containing the HA-tagged reference protein DHFR. In this
previously developed UPR (Ub protein reference) technique (40,
60), a DHFR-HA-UbR48-X-nsP4
gal fusion is cotranslationally
cleaved by DUBs at the Ub-X-nsP4
gal junction, yielding the
long-lived DHFR-HA-UbR48 reference protein and the test protein
X-nsP4
gal. In the UPR technique, the reference protein serves as an
internal control for the levels of expression, immunoprecipitation
yields, sample volumes, and other sources of sample-to-sample
variation, thereby increasing the accuracy of pulse-chase assays
(40, 60).
The previously introduced term IDx (initial
decay, i.e., the extent of degradation of a protein during the pulse of
x minutes [40]) was used to describe the in
vivo decay curves of test proteins. The term IDx
is superfluous in the case of a strictly first-order decay, which is
defined by a single half-life. However, the in vivo degradation of most
proteins deviates from first-order kinetics. Specifically, the rate of
degradation of short-lived proteins can be much higher during the
pulse, in part because a newly labeled (either nascent or just
completed) polypeptide is conformationally immature and consequently
may be targeted for degradation more efficiently than its mature
counterpart. This enhanced early degradation, previously termed the
zero-point effect (5), is described by the parameter
IDx (40). It was found that a large
fraction of the zero-point effect results from the cotranslational
degradation of nascent (being synthesized) polypeptides, which never
reach their mature size before their destruction by processive
proteolysis (G. Turner and A. Varshavsky, unpublished data).
Asn-nsP4
gal was metabolically unstable in +/+ EF cells: its
ID10 (percent degradation during the 10-min pulse) was
~45%, in comparison to ID10 of the long-lived
Met-nsP4
gal, taken as 100% (Fig. 4B and D). However, the same
Asn-nsP4
gal was completely (and reproducibly) stabilized in the
Ntan1
/
EF cells, its pulse-chase pattern
becoming indistinguishable from that of the normally long-lived
Met-nsP4
gal. In contrast, both Gln-nsP4
gal and Arg-nsP4
gal
were comparably short-lived in both +/+ and
Ntan1
/
cells (Fig. 4B to D). Taken together
with the measurements of NtN-amidase enzymatic activity
(Fig. 4A), these data indicated that the
Ntan1
/
EF cells, in contrast to congenic
wild-type cells, lacked the Asn-specific branch of the N-end rule
pathway but retained the rest of this pathway.
Motor coordination and spontaneous activity of
Ntan1
/
mice.
The
Ntan1
/
mice were fertile, apparently
healthy, and of similar size and weight as +/+ littermates, and they
cared for their offspring. These mice oriented to sound; their limb
movements and behavior appeared to be indistinguishable from those of
congenic +/+ mice. Histological examination of
Ntan1
/
tissues (small intestine, liver,
pancreas, adrenal gland, thyroid gland, kidney, ovary, testis, heart,
spleen, thymus, skeletal muscle, brain, and sciatic nerve) did not
detect abnormalities. No significant differences were observed between
+/+ and Ntan1
/
thymocytes in the ability to
undergo apoptosis in response to either radiation or dexamethasone,
suggesting that Ntan1
/
mice were not
impaired in apoptotic responses. Thus far, the only nonbehavioral
differences between +/+ and congenic Ntan1
/
mice were a weaker mitogenic response of
Ntan1
/
splenocytes and thymocytes to
phytohemagglutinin and hypersensitivity of
Ntan1
/
mice to bacterial lipopolysaccharide
(data not shown). In addition, over the last 1.5 years the frequency of
natural death among Ntan1
/
mice was ~50%
higher than among congenic +/+ mice.
/
and congenic
+/+ mice was compared using the rotarod apparatus. No difference in the
ability of mice to stay on a rotating horizontal rod was observed
between the Ntan1
/
and +/+ strains (Fig.
5A). Comparisons of physical strength
(weight retention test), of both coordination and strength (coat hanger test), and of walking patterns (hindpaw footprint test) also did not
distinguish between Ntan1
/
and +/+ mice
(Fig. 5B and C and data not shown). These and related observations
indicated that Ntan1
/
mice were not impaired
in either motor coordination, physical strength, or the learning
ability required for improved performance in repeated trials (Fig. 5A
and C).
|
/
mice was
assayed in the open-field test. By several criteria,
Ntan1
/
mice exhibited significantly lower
spontaneous activity than the congenic wild-type mice (Fig. 5F).
Specifically, Ntan1
/
mice traveled
significantly less distance (Fig. 5Fa), spent significantly more time
near the field's center (Fig. 5Fb), and consequently spent less time
within 1 cm from the walls (Fig. 5Fc). These findings will be
considered in conjunction with data from the platform-leaving test (see
Fig. 6 and Discussion).
Active and passive avoidance learning.
The shuttlebox
avoidance test compared shock-motivated learning in +/+ and congenic
Ntan1
/
mice. In this active avoidance
learning procedure, a light-conditioned stimulus precedes, by 5 s,
the unconditioned stimulus of electric shock, which remains on for
20 s. The animal can (i) cross to the safe compartment within the
5-s conditioned-stimulus interval, thus avoiding shock; (ii) cross over
during the 20-s unconditioned-stimulus interval, to escape the ongoing
shock; or (iii) not cross over and receive the full 20 s of shock
(the latter outcome is scored as the null response). Neither +/+ nor
Ntan1
/
mice showed any evidence of learning
over the 5 days of testing. However, there were performance differences
in the distribution of their responses. The two groups averaged only
four avoidance responses per day, but the +/+ mice exhibited more
escape responses and therefore fewer null responses than the
Ntan1
/
mice (Fig. 5D). Neither group showed
evidence of learning during the 5 days of retention testing, but the
number of null responses by Ntan1
/
mice
decreased significantly in comparison to their performance during
learning (data not shown), indicating that memory consolidation had
occurred in this group between the original testing and retesting 7 to
10 weeks later. Strain 129 mouse substrains are known to perform poorly
in active avoidance tests (7, 53).
/
mice took significantly longer to
enter the dark chamber than the +/+ animals. On the second day, the
entry into the dark chamber by the Ntan1
/
mice was further delayed (indicating learning), while the entry by the
+/+ mice was delayed even more, resulting in similar retention times
for either genotype (Fig. 5E).
The longer retention time of the Ntan1
/
mice
on the first day of passive learning, as well as their lower activity
in the open-field test, suggested that +/+ and congenic
Ntan1
/
mice might differ in their anxiety
levels. To investigate this, they were tested in the elevated plus
maze, which consists of two open arms and two closed arms radiating
from a center platform. The open arms are more anxiety inducing, in
that the animals with higher anxiety tend to decrease exploration of
the open arms (42). Although the
Ntan1
/
mice tended to explore the open arms
less frequently than congenic +/+ mice, the observed difference was not
statistically significant (data not shown).
A socially conditioned exploratory phenotype of
Ntan1
/
mice.
To address the finding of
lower activity in the Ntan1
/
mice (Fig. 5F)
in a different way, we devised a simple test in which the exploratory
activity was assessed in the context of a social interaction. In this
platform-leaving test, two previously untested mice,
Ntan1
/
and congenic +/+, are placed, close
together and at the same time, onto the center of a 16- by 22-cm
platform 2.7 cm in height. Thereafter one records the following
variables: the time it takes each mouse to leave the platform, until
the cutoff time of 3 min; the number and genotype of mice leaving the
platform first (in independent trials with pairs of mice); and the
number and genotypes of mice not leaving the platform by the cutoff
time (see Materials and Methods). In contrast to the standard
open-field test, a mouse in the platform-leaving test sees and smells
the second mouse on the same platform and is otherwise influenced by
the second mouse in the course of their peregrinations over the
platform. Thus, the proclivity of a mouse to explore its environment is modulated, in the platform-leaving test, by interactions with another mouse.
/
mouse paired with its congenic +/+
littermate tended to stay longer on the platform and almost never left
it by the cutoff time, in contrast to the +/+ mouse (Fig.
6A). For example, in a trial with 44 pairs of previously untested Ntan1
/
and +/+
mice, only 1 Ntan1
/
mouse left the platform
by the cutoff time, whereas 20 +/+ mice left it by that time (Fig.
6Ac). Repeated trials, at 1-h intervals, in the platform-leaving test
progressively decreased this initial difference between the paired
Ntan1
/
and +/+ mice (Fig. 6A). Note that
this decrease resulted from both an increase in the exploratory
activity of Ntan1
/
mice (in successive
trials) and a decrease in the exploratory activity of their paired +/+
littermates (e.g., Fig. 6Ac). Thus, the strongly different initial
responses of paired Ntan1
/
and +/+ mice to
the novel environment (of which the other mouse was a part) became
attenuated in subsequent trials (Fig. 6A) and nearly disappeared by the
seventh trial (data not shown).
|
/
and +/+ mice was retained if the same
test was performed with congenic nonlittermates. Strikingly, if the
test of Fig. 6A was carried out with wild-type and mutant
nonlittermates, the results were reproducibly different from those with
littermates (Fig. 6B). Specifically, in this case
Ntan1
/
mice did not stay longer on the
platform: they left it, on average, more frequently than +/+ mice, a
pattern opposite that seen with littermates (Fig. 6Bb; compare with
Fig. 6Ab). In addition, the striking difference between
Ntan1
/
and +/+ littermates in their
frequency of not leaving the platform by the cutoff time was no longer
seen in the otherwise identical tests with nonlittermates (Fig. 6Ac;
compare with Fig. 6Bc).
In the control experiments, multiple pairs of littermates of the same
genotype (either both +/+ or both Ntan1
/
)
were subjected to this test. No statistically significant differences between the platform-leaving patterns of the two mice in a pair were
observed (data not shown). The results presented in Fig. 6 were
consistently reproduced in four independent sets of tests, carried out
over 6 months with previously untested mice (at least 10 pairs of mice
per test). This socially conditioned exploratory phenotype of
Ntan1
/
mice (Fig. 6) has not been previously
described, to our knowledge, with other mouse strains.
Spatial learning and memory.
To compare spatial learning of
+/+ and congenic Ntan1
/
mice, we tested them
on the hidden platform Morris maze (where a mouse had to find a
platform submerged in water pool), using the reversal learning regimen
(see Materials and Methods) and retesting 7 or 8 weeks later. Both +/+
and Ntan1
/
mice learned to find the platform
and did not differ in either the time taken to do it or the distance
traveled; they also did not differ on these measures in the subsequent
reversal learning test, when the platform was moved to the diagonally
opposite quadrant (data not shown). However, 7 to 8 weeks later, on the
first day of retention testing, the Ntan1
/
mice were inferior to congenic +/+ mice, in that they took
significantly longer time to find the platform and traveled a
significantly longer distance before reaching it (data not shown),
suggesting that the Ntan1
/
mice have a less
effective spatial memory system.
/
mice made
significantly more errors in the acquisition phase (sessions 2 to 7)
than the congenic +/+ mice (Fig. 7A). In
the asymptotic phase (sessions 8 to 12), there were no significant differences between the two strains (Fig. 7A).
|
/
mice, especially on trial 4 (Fig.
7C).
Unlike previously tested mouse strains (30), both +/+ and
congenic Ntan1
/
mice exhibited poor learning
over the 11 days of testing, consistent with inferior performance of
strain 129-derived mice in several other learning regimens (7,
53). Thus, the significant effects described above (Fig. 7A and
C) represent largely differences in performance but indicate little
about the spatial learning ability of these mice. To determine whether
the observed effects were related to spatial competence, the identical
experiment was carried out using the same radial arm maze, except that
a nonspatial version was devised, by having different visual patterns
in each alley and rotating the maze between trials so that the
extramaze cues were rendered meaningless. In four of the arms, escape
platforms were placed, and the mice had to learn to associate a
specific visual configuration (e.g., black dots on a white background, or horizontal black and white stripes) with the presence or absence of
a platform (29). In contrast to the results with the spatial radial arm maze, no significant differences between the two genotypes were observed in the nonspatial radial arm maze, either in regard to
the overall number of errors (Fig. 7B) or in regard to the error rate
as a function of memory load (data not shown). Here, too, both +/+ and
congenic Ntan1
/
mice did not exhibit
significant learning over the 11 days of testing. Thus, no conclusions
can be drawn about spatial or nonspatial learning. At the same time, it
was possible to conclude that Ntan1
/
mice
were less effective in dealing with spatial information than the
congenic +/+ mice.
Another test of spatial learning and memory was the Lashley III maze.
This maze contains (i) cul-de-sacs that an animal has to learn to avoid
and (ii) T-choices. Both +/+ and Ntan1
/
mice
were able to learn the maze, but Ntan1
/
mice
were significantly less competent, as measured by the learning index,
T-forward errors (making a wrong T-choice), and the total number of
backward errors (Fig. 7D). When retested 7 or 8 weeks later,
Ntan1
/
mice had lower scores on the first
trial on all three measures, showing inferior long-term retention (data
not shown). These results were similar to the findings with the Morris
maze (see above), except that there was a significant difference in the
original learning of the Lashley maze favoring the +/+ mice (Fig. 7D). This difference may stem from the fact that the Lashley maze can be
learned using intramaze cues to memorize the pathway of left and right
turns, in addition to the use of extramaze cues, which are present in
both the Lashley and Morris maze tests. The results of the two radial
arm studies (Fig. 7A to C) indicated that the Ntan1
/
mice used spatial information less
effectively than the +/+ mice. In summary, the results of spatial
memory tests (Fig. 7) strongly suggested that mouse
NtN-amidase contributes to the processing of spatial
information and to long-term retention of spatial learning.
| |
DISCUSSION |
|---|
|
|
|---|
Homologs of the 310-residue mammalian NtN-amidase, encoded by the Ntan1 gene (24, 59), are present in other vertebrates, in arthropods such as D. melanogaster, and in plants such as A. thaliana but are apparently absent from the nematode Caenorhabditis elegans (data not shown). The deamidation of N-terminal (and apparently only N-terminal) Asn residue in proteins or short peptides is the only known enzymatic activity of NtN-amidase. This enzyme was operationally defined as a component of the N-end rule pathway, because it converts, in vivo, the N-terminal Asn of engineered N-end rule substrates into N-terminal Asp, which is then conjugated by R-transferase to Arg, a primary destabilizing residue (34, 63). Physiological substrates of NtN-amidase remain to be identified. Physiological substrates are also unknown for the fungal Nt-amidase, which can deamidate either N-terminal Asn or N-terminal Gln and lacks significant sequence similarities to metazoan NtN-amidase (6). In the present work, mouse NtN-amidase was studied using several approaches, including targeted mutagenesis. We report the following results.
(i) Both copies of the mouse Ntan1 gene, which encodes
NtN-amidase, were replaced by a deletion/disruption allele.
The resulting Ntan1
/
mice were viable and
fertile. Their behavioral phenotypes are described below.
(ii) EF cells from Ntan1
/
mice lacked
NtN-amidase activity, in contrast to congenic +/+ EF cells.
In addition, among the normally short-lived substrates of the N-end
rule pathway, only those bearing N-terminal Asn, a tertiary
destabilizing residue (see the introduction), became long-lived in the
Ntan1
/
EF cells. Thus, at least these cells,
and by inference the Ntan1
/
mice, lacked the
asparagine branch of the N-end rule pathway.
(iii) The Ntan1
/
EF cells contained
wild-type levels of NtQ-amidase, which mediates the
activity of N-terminal Gln, another tertiary destabilizing residue in
the N-end rule. Thus, NtN-amidase and
NtQ-amidase (the latter enzyme remains to be isolated and
characterized) are encoded by different genes.
(iv) The brains and testes of +/+ mice contained, respectively, the
1.4- and 1.6-kb Ntan1 mRNAs. In addition, the testes but not
the brains of +/+ mice also contained the Ntan1-derived RNAs of 1.1 and 4 kb. The brains and testes of
Ntan1
/
mice lacked, respectively, the 1.4- and 1.6-kb Ntan1 mRNAs. However, the testes of
Ntan1
/
mice retained the testis-specific
1.1- and 4-kb Ntan1-derived RNAs, which were found to lack
the 5'-half of the Ntan1 ORF (including the region deleted
in Ntan1
/
mice) and to encompass the 3' half
of Ntan1 ORF. Whether these testis-specific transcripts are
physiologically relevant in +/+ mice remains to be determined.
(v) Deletion-disruption of Ntan1 in the
Ntan1
/
mice did not significantly change the
levels of mRNAs encoding other components of the N-end rule pathway,
such as ATE1p (R-transferase), UBR1p (E3
, the pathway's E3
component), UBR2p (a homolog of UBR1p), and mHR6Bp (E214K).
(vi) Ntan1, which is expressed, at different levels, in most
if not all tissues of adult mice (24), was found through in situ hybridization to be particularly strongly expressed in the branchial arches, the tail bud, and the limb buds of E10 embryos. This
expression pattern was indistinguishable from that of Ubr1 (36), consistent with the assignment of NTAN1p
(NtN-amidase) and UBR1p (E3
) to the same pathway.
(vii) An NTAN1p-GFP fusion was enriched in the nucleus of transfected mouse 3T3 cells, in contrast to free GFP, which was uniformly distributed. NTAN1p-GFP was also present in the nucleus-proximal cytoplasm but was apparently much less abundant at the cells' periphery. This localization pattern of the mammalian NtN-amidase is quite different from that of the S. cerevisiae NTA1-encoded Nt-amidase, most of which is located in the yeast mitochondria (H. R. Wang and A. Varshavsky, unpublished data). In contrast to the mammalian NtN-amidase, the yeast Nt-amidase, which has no significant sequence similarities to the metazoan enzyme, can deamidate either N-terminal Asn or N-terminal Gln (6).
(viii) While the abnormal phenotypes of
Ntan1
/
mice are apparently not confined to
behavioral/cognitive alterations (see Results), it is the latter that
have been analyzed in some detail. Briefly, the
Ntan1
/
mice were indistinguishable from
congenic +/+ mice in motor coordination and general physical
performance but had reduced spontaneous activity and less effective
spatial memory. Remarkably, the exploratory behavior of
Ntan1
/
mice was found to be particularly
different from that of congenic +/+ mice in the presence of social
interactions. If a previously untested
Ntan1
/
mouse was placed on a small, slightly
elevated platform with its +/+ littermate (which it grew up with in the
same cage), the Ntan1
/
mouse left the
platform much more slowly than the +/+ mouse. In contrast, when an
Ntan1
/
mouse was subjected to this test in
the presence of a congenic nonlittermate +/+ mouse, it tended to leave
the platform faster than the +/+ mouse, even though
Ntan1
/
mice exhibited diminished exploratory
activity when tested alone (Fig. 6).
Our working hypothesis is that Ntan1
/
mice
are socially recessive, in relation to congenic +/+ mice, and in
addition have a lower spontaneous exploratory activity. In a relatively
unstressful setting, such as when it is placed on the platform
side-by-side with a (familiar) littermate, the behavior of
Ntan1
/
mice is governed largely by their
inherently lower exploratory activity, yielding the observation that
these mice leave the platform much more slowly than their +/+
littermates (Fig. 6A). By contrast, in an otherwise identical test with
a +/+ nonlittermate, the postulated social recessiveness of
Ntan1
/
mice becomes their behavior-governing
trait. As a result, they leave the platform faster than the +/+
nonlittermates, to reduce the proximity-induced anxiety (Fig. 6B).
The socially conditioned exploratory phenotype of
Ntan1
/
mice, identified through the
platform-leaving test (Fig. 6), has not been previously described, to
our knowledge, with other mouse strains. It is difficult to compare
this finding with behavioral studies of other mouse mutants, because
most of the earlier analyses of exploratory behavior used solitary
mice. An example of differential effect of stress on a specific mutant
is provided by the analysis of mice lacking the serotonin receptor 1A.
These mice exhibited decreased exploratory activity and increased fear
of aversive environments (in comparison to +/+ mice), as measured by
the open-field test and the elevated plus-maze test, respectively.
However, the mutant mice were indistinguishable from +/+ littermates in
a less stressful setting such as their home cages (50).
A parsimonious molecular interpretation of our results (Fig. 5 to 7) is
that a normally short-lived regulatory protein(s) that is targeted for
degradation by the N-end rule pathway through the protein's N-terminal
Asn becomes long-lived in Ntan1
/
mice. The
resulting increase in the steady-state concentration of this protein(s)
alters the functioning of relevant neural networks in the adult brain
or, nonalternatively, changes these networks in the course of their
establishment during development. That the inactivation of a
Ub-dependent proteolytic pathway could affect cognitive functions is
illustrated, for example, by the identification of UBE3A as
a human gene encoding an E3 protein of the Ub system called E6AP. This
gene is mutated in the Angelman's syndrome, the symptoms of which
include motor dysfunction and mental retardation (33, 45).
Mice lacking UBE3A exhibit deficits in contextual learning
and long-term potentiation (31).
The absence of severe impairments in the
Ntan1
/
mice should make them particularly
suitable as vehicles for the approaches to conditional mutagenesis that
use conditional destabilization of a protein of interest. One version
of this approach could use a transgenic mouse strain that lacks
endogenous Ntan1 and expresses this gene from one of the
previously constructed promoters whose activity can be controlled by
small molecules such as tetracycline or ecdysone (9). If a
protein of interest is modified, through knock-in mutagenesis and the
Ub fusion technique (63), to bear an Asn-containing
N-degron, the resulting protein would be long-lived in the absence of
the Ntan1-encoded NtN-amidase but short-lived,
and therefore scarce, in the presence of NtN-amidase. In
this method, the steady-state level, and hence the activity, of a
protein of interest is controlled through Ntan1-dependent, regulated changes of the protein's metabolic stability. One advantage of this strategy is that it does not require alterations of a promoter
that expresses a gene of interest, thereby avoiding potential perturbations of the promoter regulation during development and differentiation. This approach may be combined with the existing technologies for conditional mutagenesis of the mouse (13,
55), enhancing them through regulated degradation of a protein of interest.
Inasmuch as behavior is an emergent property of highly complex neural
networks interacting with the musculoskeletal apparatus, a behavioral
alteration that is caused by the absence of a specific protein from the
brain is difficult to understand in terms of higher-order neural events
even in the case of a protein (e.g., a neurotransmitter-gated ion
channel) whose molecular function in the individual neurons is clear.
The difficulty is further increased in the case of a protein such as
NtN-amidase, whose physiological substrates remain to be
identified. At the same time, the absence of a priori reasons to
suspect a specific role for NtN-amidase in the brain's
functions and the robustness of behavioral differences between the
Ntan1
/
and congenic +/+ mice (Fig. 5 to 7)
make these findings particularly intriguing. Further advances in this
inquiry will require, at minimum, the identification of physiological
substrates of NtN-amidase. The availability of
Ntan1
/
mice and cell lines derived from them
should facilitate the discovery of these substrates.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to members of the Caltech Transgenic Facility, especially S. Pease, B. Kennedy, and A. Granados, for the care of mice and expert technical help. We thank S. Grigoryev for helpful discussions at the beginning of this study, N. Barteneva for assistance with some of the early experiments, S. Offermanns for advice and help with preparation of embryonic fibroblasts, and R. C. Mulligan and R. Jaenisch for gifts of plasmids.
This work was supported by grants GM31530 and DK39520 from the National Institutes of Health to A.V.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Alexander Varshavsky, Division of Biology, 147-75, Caltech, 1200 East California Blvd., Pasadena, CA 91125. Phone: (626) 395-3785. Fax: (626) 440-9821. E-mail: avarsh{at}caltech.edu.
Present address: Institute for Genetics, University of Cologne,
Cologne D-50931, Germany.
Present address: Department of Pediatrics and Psychiatry,
University of Colorado School of Medicine, Denver, CO 80262.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alagramam, K., F. Naider, and J. M. Becker. 1995. A recognition component of the ubiquitin system is required for peptide transport in Saccharomyces cerevisiae. Mol. Microbiol. 15:225-234[CrossRef][Medline]. |
| 2. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. A. Smith, J. G. Seidman, and K. Struhl (ed.). 1998. Current protocols in molecular biology. Wiley-Interscience, New York, N.Y. |
| 3. |
Bachmair, A.,
D. Finley, and A. Varshavsky.
1986.
In vivo half-life of a protein is a function of its amino-terminal residue.
Science
234:179-186 |
| 4. | Bachmair, A., and A. Varshavsky. 1989. The degradation signal in a short-lived protein. Cell 56:1019-1032[CrossRef][Medline]. |
| 5. |
Baker, R. T., and A. Varshavsky.
1991.
Inhibition of the N-end rule pathway in living cells.
Proc. Natl. Acad. Sci. USA
87:2374-2378 |
| 6. |
Baker, R. T., and A. Varshavsky.
1995.
Yeast N-terminal amidase. A new enzyme and component of the N-end rule pathway.
J. Biol. Chem.
270:12065-12074 |
| 7. | Balogh, S. A., C. S. McDowell, A. Stavnezer, and V. H. Denenberg. 1999. A behavioral and neuroanatomical assessment of an inbred substrain of 129 mice, with behavioral comparisons to C57BL/6J mice. Brain Res. 836:38-48[CrossRef][Medline]. |
| 8. |
Balzi, E.,
M. Choder,
W. Chen,
A. Varshavsky, and A. Goffeau.
1990.
Cloning and functional analysis of the arginyl-tRNA-protein transferase gene ATE1 of Saccharomyces cerevisiae.
J. Biol. Chem.
265:7464-7471 |
| 9. |
Baron, U.,
D. Schnappinger,
V. Helbl,
M. Gossen,
W. Hillen, and H. Bujard.
1999.
Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes.
Proc. Natl. Acad. Sci. USA
96:1013-1018 |
| 10. | Baumeister, W., J. Walz, F. Zühl, and E. Seemüller. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367-380[CrossRef][Medline]. |
| 11. | Beaudin, S., and R. Lalonde. 1997. The effects of pentobarbital on spatial learning, motor coordination, and exploration. Pharmacol. Biochem. Behav. 57:111-114[CrossRef][Medline]. |
| 12. | Byrd, C., G. C. Turner, and A. Varshavsky. 1998. The N-end rule pathway controls the import of peptides through degradation of a transcriptional repressor. EMBO J. 17:269-277[CrossRef][Medline]. |
| 13. |
Capecchi, M. R.
1989.
Altering the genome by homologous recombination.
Science
244:1288-1292 |
| 14. |
Chang, S. E.,
J. Keen,
E. B. Lane, and J. Taylor-Papadimitriou.
1982.
Establishment and characterization of SV40-transformed human breast epithelial cell lines.
Cancer Res.
42:2040-2053 |
| 15. |
Chau, V.,
J. W. Tobias,
A. Bachmair,
D. Marriott,
D. J. Ecker,
D. K. Gonda, and A. Varshavsky.
1989.
A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.
Science
243:1576-1583 |
| 16. | Conlon, R. A., and J. Rossant. 1992. Exogenous retinoic acid rapidly induces anterior ectopic expression of murine Hox-2 genes in vivo. Development 116:357-368[Medline]. |
| 17. | Coux, O., K. Tanaka, and A. L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801-817[CrossRef][Medline]. |
| 18. | Davydov, I. V., D. Patra, and A. Varshavsky. 1998. The N-end rule pathway in Xenopus egg extracts. Arch. Biochem. Biophys. 357:317-325[CrossRef][Medline]. |
| 19. |
deGroot, R. J.,
T. Rümenapf,
R. J. Kuhn, and J. H. Strauss.
1991.
Sindbis virus RNA polymerase is degraded by the N-end rule pathway.
Proc. Natl. Acad. Sci. USA
88:8967-8971 |
| 20. |
DeMartino, G. N., and C. A. Slaughter.
1999.
The proteasome, a novel protease regulated by multiple mechanisms.
J. Biol. Chem.
274:22123-22126 |
| 21. | Denenberg, V. H., N. Talgo, D. A. Carroll, S. Freter, and R. Deni. 1991. A computer-aided procedure for measuring Lashley III maze performance. Physiol. Behav. 50:857-861[CrossRef][Medline]. |
| 22. | Denenberg, V. H., N. W. Talgo, N. S. Waters, and G. H. Kenner. 1990. A computer-aided procedure for measuring swim rotation. Physiol. Behav. 47:1023-1025[CrossRef][Medline]. |
| 23. |
Gonda, D. K.,
A. Bachmair,
I. Wünning,
J. W. Tobias,
W. S. Lane, and A. Varshavsky.
1989.
Universality and structure of the N-end rule.
J. Biol. Chem.
264:16700-16712 |
| 24. |
Grigoryev, S.,
A. E. Stewart,
Y. T. Kwon,
S. M. Arfin,
R. A. Bradshaw,
N. A. Jenkins,
N. G. Copeland, and A. Varshavsky.
1996.
A mouse amidase specific for N-terminal asparagine. The gene, the enzyme, and their function in the N-end rule pathway.
J. Biol. Chem.
271:28521-28532 |
| 25. | Haas, A. J., and T. J. Siepman. 1997. Pathways of ubiquitin conjugation. FASEB J. 11:1257-1268[Abstract]. |
| 26. | Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 76:425-479[CrossRef]. |
| 27. | Hochstrasser, M. 1996. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30:405-439[CrossRef][Medline]. |
| 28. | Hondermarck, H., J. Sy, R. A. Bradshaw, and S. M. Arfin. 1992. Dipeptide inhibitors of ubiquitin-mediated protein turnover prevent growth factor-induced neurite outgrowth in rat pheochromocytoma PC12 cells. Biochem. Biophys. Res. Commun. 30:280-288. |
| 29. | Hyde, L. A., and V. H. Denenberg. 1999. BXSB mice can learn complex pattern discrimination. Physiol. Behav. 66:437-439[CrossRef][Medline]. |
| 30. | Hyde, L. A., B. J. Hoplight, and V. H. Denenberg. 1998. Water version of the radial-arm maze: learning in three inbred strains of mice. Brain Res. 785:236-244[CrossRef][Medline]. |
| 31. | Jiang, Y. H., D. Armstrong, U. Albrecht, C. M. Atkins, J. L. Noebels, G. Eichele, J. D. Sweatt, and A. L. Beaudet. 1998. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21:799-811[CrossRef][Medline]. |
| 32. | Johnson, E. S., D. K. Gonda, and A. Varshavsky. 1990. Cis-trans recognition and subunit-specific degradation of short-lived proteins. Nature 346:287-291[CrossRef][Medline]. |
| 33. | Kishino, T., M. Lalande, and J. Wagstaff. 1997. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15:70-73[CrossRef][Medline]. |
| 34. |
Kwon, Y. T.,
A. S. Kashina, and A. Varshavsky.
1999.
Alternative splicing results in differential expression, activity, and localization of the two forms of arginyl-tRNA-protein transferase, a component of the N-end rule pathway.
Mol. Cell. Biol.
19:182-193 |
| 35. |
Kwon, Y. T.,
F. Lévy, and A. Varshavsky.
1999.
Bivalent inhibitor of the N-end rule pathway.
J. Biol. Chem.
274:18135-18139 |
| 36. |
Kwon, Y. T.,
Y. Reiss,
V. A. Fried,
A. Hershko,
J. K. Yoon,
D. K. Gonda,
P. Sangan,
N. G. Copeland,
N. A. Jenkins, and A. Varshavsky.
1998.
The mouse and human genes encoding the recognition component of the N-end rule pathway.
Proc. Natl. Acad. Sci. USA
95:7898-7903 |
| 37. | Laney, J. D., and M. Hochstrasser. 1999. Substrate targeting in the ubiquitin system. Cell 97:427-430[CrossRef][Medline]. |
| 38. |
Lawson, T. G.,
D. L. Gronros,
P. E. Evans,
M. C. Bastien,
K. M. Michalewich,
J. K. Clark,
J. H. Edmonds,
K. H. Graber,
J. A. Werner,
B. A. Lurvey, and J. M. Cate.
1999.
Identification and characterization of a protein destruction signal in the encephalomyocarditis virus 3C protease.
J. Biol. Chem.
274:9871-9880 |
| 39. | Lecker, S. H., V. Solomon, S. R. Price, Y. T. Kwon, W. E. Mitch, and A. L. Goldberg. 1999. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J. Clin. Investig. 104:1411-1420[Medline]. |
| 40. |
Lévy, F.,
N. Johnsson,
T. Rumenapf, and A. Varshavsky.
1996.
Using ubiquitin to follow the metabolic fate of a protein.
Proc. Natl. Acad. Sci. USA
93:4907-4912 |
| 41. | Li, J., and C. Pickart. 1995. Inactivation of arginyl-tRNA protein transferase by a bifunctional arsenoxide: identification of residues proximal to arsenoxide site. Biochemistry 34:139-147[CrossRef][Medline]. |
| 42. | Lister, R. G. 1987. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185[Medline]. |
| 43. |
Madura, K., and A. Varshavsky.
1994.
Degradation of G by the N-end rule pathway.
Science
265:1454-1458 |
| 44. |
Maniatis, T.
1999.
A ubiquitin ligase complex essential for the NF- B, Wnt/Wingless, and Hedgehog signaling pathways.
Genes Dev.
13:505-510 |
| 45. | Matsuura, T., J. S. Sutcliffe, P. Fang, R. J. Galjaard, Y. H. Jiang, C. S. Benton, J. M. Rommens, and A. L. Beaudet. 1997. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat. Genet. 15:74-77[CrossRef][Medline]. |
| 46. | Morris, R. 1984. Development of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11:47-60[CrossRef][Medline]. |
| 47. |
Ota, I. M., and A. Varshavsky.
1993.
A yeast protein similar to bacterial two-component regulators.
Science
262:566-569 |
| 48. | Peters, J.-M., R. W. King, and R. J. Deshaies. 1998. Cell cycle control by ubiquitin-dependent proteolysis, p. 345-387. In J. M. Peters, J. R. Harris, and D. Finley (ed.), Ubiquitin and the biology of the cell. Plenum Press, New York, N.Y. |
| 49. | Pickart, C. M. 1997. Targeting of substrates to the 26S proteasome. FASEB J. 11:1055-1066[Abstract]. |
| 50. |
Ramboz, S.,
R. Oosting,
D. A. Amara,
H. F. Kung,
P. Blier,
M. Mendelsohn,
J. J. Mann,
D. Brunner, and R. Hen.
1998.
Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.
Proc. Natl. Acad. Sci. USA
95:14476-14481 |
| 51. | Rechsteiner, M. 1998. The 26S proteasome, p. 147-189. In J. M. Peters, J. R. Harris, and D. Finley (ed.), Ubiquitin and the biology of the cell. Plenum Press, New York, N.Y. |
| 52. | Robertson, E. J. 1987. Embryo-derived stem cell lines, p. 71-112. In E. J. Robertson (ed.), Teratocarcinomas and embryonic stem cells: a practical approach. IRL Press, Oxford, United Kingdom. |
| 53. | Royce, J. R. 1972. Avoidance conditioning in nine strains of inbred mice using optimal stimulus parameters. Behav. Genet. 2:107-110[CrossRef][Medline]. |
| 54. | Schauber, C., L. Chen, P. Tongaonkar, I. Vega, and K. Madura. 1998. Sequence elements that contribute to the degradation of yeast G-alpha. Genes Cells 3:307-319[Abstract]. |
| 55. |
Schwenk, F.,
R. Kuhn,
P. O. Angrand,
K. Rajewsky, and A. F. Stewart.
1998.
Temporally and spatially regulated somatic mutagenesis in mice.
Nucleic Acids Res.
26:1427-1432 |
| 56. |
Sijts, A. J.,
I. Pilip, and E. G. Pamer.
1997.
The Listeria monocytogenes-secreted p60 protein is an N-end rule substrate in the cytosol of infected cells. Implications for major histocompatibility complex class I antigen processing of bacterial proteins.
J. Biol. Chem.
272:19261-19268 |
| 57. |
Solomon, V.,
V. Baracos,
P. Sarraf, and A. Goldberg.
1998.
Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway.
Proc. Natl. Acad. Sci. USA
95:12602-12607 |
| 58. | Stewart, A. 1995. Trends in genetics nomenclature guide. Elsevier Science, Ltd., Cambridge, United Kingdom. |
| 59. |
Stewart, A. E.,
S. M. Arfin, and R. A. Bradshaw.
1995.
The sequence of porcine protein NH2-terminal asparagine amidohydrolase. A new component of the N-end rule pathway.
J. Biol. Chem.
270:25-28 |
| 60. | Suzuki, T., and A. Varshavsky. 1999. Degradation signals in the lysine-asparagine sequence space. EMBO J. 18:6017-6026[CrossRef][Medline]. |
| 61. | Taban, C. H., H. Hondermarck, R. A. Bradshaw, and B. Boilly. 1996. Effect of a dipeptide inhibiting ubiquitin-mediated protein degradation on nerve-dependent limb regeneration in the newt. Experientia 52:865-870[CrossRef][Medline]. |
| 62. |
Tobias, J. W., and A. Varshavsky.
1991.
Cloning and functional analysis of the ubiquitin-specific protease gene UBP1 of Saccharomyces cerevisiae.
J. Biol. Chem.
266:12021-12028 |
| 63. |
Varshavsky, A.
1996.
The N-end rule: functions, mysteries, uses.
Proc. Natl. Acad. Sci. USA
93:12142-12149 |
| 64. | Varshavsky, A. 1997. The ubiquitin system. Trends Biochem. Sci. 22:383-387[CrossRef][Medline]. |
| 65. | Wang, Y. M., and N. A. Ingoglia. 1997. N-terminal arginylation of sciatic nerve and brain proteins following injury. Neurochem. Res. 22:1453-1459[CrossRef][Medline]. |
| 66. | Wilkinson, K., and M. Hochstrasser. 1998. The deubiquitinating enzymes, p. 99-126. In J.-M. Peters, J. R. Harris, and D. Finley (ed.), Ubiquitin and the biology of the cell. Plenum Press, New York, N.Y. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»